These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 8667864)
1. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. UK Haemophilia Centre Directors' Organisation. Darby SC; Ewart DW; Giangrande PL; Spooner RJ; Rizza CR Lancet; 1996 Jun; 347(9015):1573-9. PubMed ID: 8667864 [TBL] [Abstract][Full Text] [Related]
2. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation. Darby SC; Ewart DW; Giangrande PL; Spooner RJ; Rizza CR; Dusheiko GM; Lee CA; Ludlam CA; Preston FE Lancet; 1997 Nov; 350(9089):1425-31. PubMed ID: 9371165 [TBL] [Abstract][Full Text] [Related]
3. Mortality before and after HIV infection in the complete UK population of haemophiliacs. UK Haemophilia Centre Directors' Organisation. Darby SC; Ewart DW; Giangrande PL; Dolin PJ; Spooner RJ; Rizza CR Nature; 1995 Sep; 377(6544):79-82. PubMed ID: 7659168 [TBL] [Abstract][Full Text] [Related]
4. Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: report on behalf of the directors of haemophilia centres in the United Kingdom. Darby SC; Rizza CR; Doll R; Spooner RJ; Stratton IM; Thakrar B BMJ; 1989 Apr; 298(6680):1064-8. PubMed ID: 2497891 [TBL] [Abstract][Full Text] [Related]
5. Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion. Touloumi G; Karafoulidou A; Gialeraki A; Katsarou O; Milona I; Kapsimali V; Mandalaki T; Hatzakis A J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Sep; 19(1):89-97. PubMed ID: 9732075 [TBL] [Abstract][Full Text] [Related]
6. Immune status in HIV-1-infected men and boys with haemophilia in the United Kingdom. UK Haemophilia Centre Directors' Organisation. Ewart DW; Darby SC; Lee CA; Giangrande PL; Spooner RJ; Phillips AN; Ludlam CA AIDS; 1998 May; 12(8):956-8. PubMed ID: 9631154 [No Abstract] [Full Text] [Related]
7. The AIDS incubation period in the UK estimated from a national register of HIV seroconverters. UK Register of HIV Seroconverters Steering Committee. AIDS; 1998 Apr; 12(6):659-67. PubMed ID: 9583607 [TBL] [Abstract][Full Text] [Related]
8. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet; 2000 Apr; 355(9210):1131-7. PubMed ID: 10791375 [TBL] [Abstract][Full Text] [Related]
9. Factors associated with progression to AIDS and mortality in a cohort of HIV-infected patients with hemophilia followed up since seroconversion. Santagostino E; Gringeri A; Cultraro D; Tradati F; Siracusano L; Marinoni A; Mannucci PM Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):371-80. PubMed ID: 7580830 [TBL] [Abstract][Full Text] [Related]
10. AIDS and hemophilia: experience in the La Paz Hemophilia Center. Magallón Martínez M; Ortega F; Pinilla J Haemostasis; 1992; 22(5):281-92. PubMed ID: 1362177 [TBL] [Abstract][Full Text] [Related]
11. Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study. Sabin CA; Griffioen A; Yee TT; Emery VC; Herrero-Martinez E; Phillips AN; Lee CA Lancet; 2002 Nov; 360(9345):1546-51. PubMed ID: 12443592 [TBL] [Abstract][Full Text] [Related]
12. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. O'Brien TR; Blattner WA; Waters D; Eyster E; Hilgartner MW; Cohen AR; Luban N; Hatzakis A; Aledort LM; Rosenberg PS; Miley WJ; Kroner BL; Goedert JJ JAMA; 1996 Jul; 276(2):105-10. PubMed ID: 8656501 [TBL] [Abstract][Full Text] [Related]
13. [Progression to AIDS among HIV-seropositive hemophiliacs]. Lorenzo JI; Molina R; Senent ML; Monzó E; Lerma MA; Dasí MA; Monteagudo E; Aznar JA Sangre (Barc); 1992 Jun; 37(3):169-74. PubMed ID: 1440093 [TBL] [Abstract][Full Text] [Related]
14. The impact of HIV on mortality rates in the complete UK haemophilia population. Darby SC; Kan SW; Spooner RJ; Giangrande PL; Lee CA; Makris M; Sabin CA; Watson HG; Wilde JT; Winter M; AIDS; 2004 Feb; 18(3):525-33. PubMed ID: 15090806 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of antibody to HIV in haemophiliacs in the United Kingdom: a second survey. AIDS Group of the United Kingdom Haemophilia Centre Directors with the co-operation of the United Kingdom Haemophilia Centre Directors. Clin Lab Haematol; 1988; 10(2):187-91. PubMed ID: 3262033 [TBL] [Abstract][Full Text] [Related]
16. Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients. Katsarou O; Touloumi G; Antoniou A; Kouramba A; Hatzakis A; Karafoulidou A Haemophilia; 2005 Jul; 11(4):360-5. PubMed ID: 16011588 [TBL] [Abstract][Full Text] [Related]
17. Time from infection with HIV to onset of AIDS in patients with haemophilia in the UK. Darby SC; Doll R; Thakrar B; Rizza CR; Cox DR Stat Med; 1990 Jun; 9(6):681-9. PubMed ID: 2218171 [TBL] [Abstract][Full Text] [Related]
18. HIV-1 disease progression and AIDS-defining disorders in rural Uganda. Morgan D; Maude GH; Malamba SS; Okongo MJ; Wagner HU; Mulder DW; Whitworth JA Lancet; 1997 Jul; 350(9073):245-50. PubMed ID: 9242801 [TBL] [Abstract][Full Text] [Related]
19. Progression to AIDS in relation to clinical factors and clotting product consumption. A 14-year follow-up of a cohort of 52 Dutch HIV-1-infected haemophilic patients. Roosendaal G; van der Schouw Y; Mauser-Bunschoten E; Borleffs J; van den Berg H Vox Sang; 1998; 75(4):261-6. PubMed ID: 9873260 [TBL] [Abstract][Full Text] [Related]
20. Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group. Spira R; Lepage P; Msellati P; Van De Perre P; Leroy V; Simonon A; Karita E; Dabis F Pediatrics; 1999 Nov; 104(5):e56. PubMed ID: 10545582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]